About Rapid Genomics
Rapid Genomics is a company based in Gainesville (United States) founded in 2011 was acquired by LGC in April 2022.. Rapid Genomics has raised $300 thousand across 1 funding round from investors including LGC. Rapid Genomics offers products and services including KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits. Rapid Genomics operates in a competitive market with competitors including Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
- Headquarter Gainesville, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rapid Genomics Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rapid Genomics
Rapid Genomics offers a comprehensive portfolio of products and services, including KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reagents for qPCR-based genotyping in agriculture.
Custom oligonucleotides for DNA and RNA applications.
Devices for high-throughput PCR and genotyping.
Kits for amplicon-based targeted sequencing workflows.
Funding Insights of Rapid Genomics
Rapid Genomics has successfully raised a total of $300K through 1 strategic funding round. The most recent funding activity was a Seed round of $300 thousand completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $300,000
-
First Round
First Round
(15 Oct 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2015 | Amount | Seed - Rapid Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rapid Genomics
Rapid Genomics has secured backing from 1 investor. Prominent investors backing the company include LGC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Molecular biology reagents and services are supplied to biotech industries.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rapid Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rapid Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rapid Genomics Comparisons
Competitors of Rapid Genomics
Rapid Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| domain | founded_year | HQ Location |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| domain | founded_year | HQ Location |
Next-generation gene sequencing and multi-omics technologies are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rapid Genomics
Frequently Asked Questions about Rapid Genomics
When was Rapid Genomics founded?
Rapid Genomics was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Where is Rapid Genomics located?
Rapid Genomics is headquartered in Gainesville, United States.
Is Rapid Genomics a funded company?
Rapid Genomics is a funded company, having raised a total of $300K across 1 funding round to date. The company's 1st funding round was a Seed of $300K, raised on Oct 15, 2015.
What does Rapid Genomics do?
Rapid Genomics was founded in 2011 in Gainesville, United States, and operates in the genomics sector focused on agriculture. DNA sequencing services are offered to enhance crops and livestock, utilizing capture-sequencing technology for custom targeted applications. Additional services include RNA sequencing, whole genome sequencing, ultraconserved elements analysis, next-generation sequencing, and bioinformatics support. Operations are centered on providing these tools to research and development efforts in the field.
Who are the top competitors of Rapid Genomics?
Rapid Genomics's top competitors include Novogene Corporation, Singular Genomics and Source BioScience.
What products or services does Rapid Genomics offer?
Rapid Genomics offers KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits.
Who are Rapid Genomics's investors?
Rapid Genomics has 1 investor. Key investors include LGC.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.